446 related articles for article (PubMed ID: 19727403)
1. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
Dunn LK; Mohammad KS; Fournier PG; McKenna CR; Davis HW; Niewolna M; Peng XH; Chirgwin JM; Guise TA
PLoS One; 2009 Sep; 4(9):e6896. PubMed ID: 19727403
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
[TBL] [Abstract][Full Text] [Related]
4. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
[TBL] [Abstract][Full Text] [Related]
7. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies to target TGF-β in the treatment of bone metastases.
Buijs JT; Juárez P; Guise TA
Curr Pharm Biotechnol; 2011 Dec; 12(12):2121-37. PubMed ID: 21619539
[TBL] [Abstract][Full Text] [Related]
9. β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression.
Shenoy SK; Han S; Zhao YL; Hara MR; Oliver T; Cao Y; Dewhirst MW
Oncogene; 2012 Jan; 31(3):282-92. PubMed ID: 21685944
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
13. HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
Devignes CS; Aslan Y; Brenot A; Devillers A; Schepers K; Fabre S; Chou J; Casbon AJ; Werb Z; Provot S
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E992-E1001. PubMed ID: 29339479
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
15. TGF-β in cancer and bone: implications for treatment of bone metastases.
Juárez P; Guise TA
Bone; 2011 Jan; 48(1):23-9. PubMed ID: 20699127
[TBL] [Abstract][Full Text] [Related]
16. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis.
Zarin B; Nedaeinia R; Laher I; Manian M; Javanmard SH
Tumour Biol; 2023; 45(1):111-126. PubMed ID: 37927290
[TBL] [Abstract][Full Text] [Related]
17. Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
Pollari S; Leivonen SK; Perälä M; Fey V; Käkönen SM; Kallioniemi O
PLoS One; 2012; 7(5):e37361. PubMed ID: 22629385
[TBL] [Abstract][Full Text] [Related]
18. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
[TBL] [Abstract][Full Text] [Related]
20. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
